Apr 7, 2022
Natasha Drapeau is the Executive Vice President of BioSig Technologies, pioneers in advanced biomedical signal processing solutions that will unlock the future of bioelectronic medicine, starting with the PURE EP™ System and their work on common and complex cardiac arrhythmia. Approximately more than half of patients...
Apr 7, 2022
Natasha Drapeau is the Executive Vice President of BioSig Technologies, pioneers in advanced biomedical signal processing solutions that will unlock the future of bioelectronic medicine, starting with the PURE EP™ System and their work on common and complex cardiac arrhythmia. Approximately more than half of patients...
Jan 4, 2022
Dr. Nick West is the Chief Medical Officer and DVP, Global Medical Affairs in Vascular for Abbott and is back on the podcast to talk about their Beyond Intervention global research. This second annual survey looks at hurdles in the patient journey to see where improvements can be made in the patient experience.
Nick...
Jan 4, 2022
Dr. Nick West is the Chief Medical Officer and DVP, Global Medical Affairs in Vascular for Abbott and is back on the podcast to talk about their Beyond Intervention global research. This second annual survey looks at hurdles in the patient journey to see where improvements can be made in the patient experience.
Nick...
Dec 13, 2021
Dr. Waqaas Al-Siddiq is the Founder and CEO of Biotricity and a leader in the development of mobile cardiac telemetry, MCT, devices to provide real-time, continuous monitoring of at-risk patients.
Waqaas explains, "One of the core areas that we strongly focus on is long-term data collection in this real-time...